By now, we are hearing horror stories coming from Italy on the number of patients and healthcare workers during from COVID-19; I reached out to my friend and colleague Stefano Luminari, MD, a professor of oncology at the University of Modena (Italy) to provide an update on the COVID-19 situation in Italy, including operational measures undertaken when there was an increase in demand for ICU hospital beds, the country’s underestimation of the seriousness of the disease at the beginning of the outbreak, how hospital staff are protecting themselves from the virus, and more.
what can we learn from our beloved colleague in Italy?
Dr Nabhan and the podcast guests have no relevant financial disclosures. This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
